ArticleInternational journal of medical sciences2025

Real-World Safety of Anti-EGFR Antibodies: 20-Year Pharmacovigilance of Cetuximab and Panitumumab.

Liang-Yan Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.